New registry monitors blood vessel blocking plugs in Real-World use
NCT ID NCT04044443
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is a registry that follows 108 adults who received IMPEDE or IMPEDE-FE plugs to block blood vessels in the arms or legs. The goal is to see how safe and effective these devices are in everyday medical practice. Researchers track serious side effects and whether the plugs successfully stop blood flow to the target area.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
108 people
The number who actually took part.
- Started
-
Jul 2019
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult study participants considered candidates for a peripheral vascular embolization procedure
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Study participant is ≥18 years of age * Study participant is considered a candidate for arterial or venous embolization of the peripheral vasculature Exclusion Criteria: * Study participant has an inability to provide written informed consent * Study participant/treatment outside of the approved study device labeling, instructions for use (IFU) * Study participant is a prisoner or member of other vulnerable population
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Peripheral vascular embolization are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Klinikum München rechts der Isar
München, 81675, Germany
-
Klinikum Nürnberg
Nuremberg, 90471, Germany
-
Klinikum StuttGart
Stuttgart, 70174, Germany
-
St George's Hospital (St George's University Hospitals NHS Foundation Trust)
London, United Kingdom
-
St Mary's Hospital (Imperial College Healthcare NHS Trust)
London, United Kingdom
-
UNIVERSITÄTSKLINIKUM LEIPZIG AöR
Leipzig, 04103, Germany
-
Uniklinikum Würzburg
Würzburg, 97080, Germany
-
Universitätsklinikum Carl-Gustav-Carus an der Technischen Universität Dresden
Dresden, 01307, Germany
-
Universitätsklinikum Heidelberg
Heidelberg, 69120, Germany
-
Universitätsklinikum Schleswig-Holstein (Campus Kiel)
Kiel, 24105, Germany